DocWire News Editors

DocwireNews

There is more COVID news in this week&rsquo;s Round-up, including an interview with Dr. Carl J. &ldquo;Chip&rdquo; Lavie about some commonly used drugs for treating hypertension and their use in patients with COVID-19.&nbsp;<h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/ace-inhibitors-and-arbs-in-hypertensive-covid-19-patients-lavie-interview/">Interview with Chip Lavie, MD</a></h2>Carl J. &ldquo;Chip&rdquo; Lavie, MD, of the John Ochsner Heart and Vascular Institute in New Orleans, talks about a newly published review in the Mayo Clinic Proceedings looking at the use of angiotensin receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors in hypertensive patients who also have diagnosed <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/organizations-call-on-pharmacy-boards-to-make-sure-patients-receive-chloroquine-and-hydroxychloroquine-a-life-saving-lupus-therapy-amid-covid-19-experimental-use/">COVID-19</a>.To read the&nbsp;DocWire News&nbsp;article covering the study,&nbsp;<a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/ace-inhibitors-angiotensin-receptor-blockers-renin-hypertension/">click here</a>.To read the paper,&nbsp;<a href="https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_ft95_3_5-1585588116123.pdf" target="_blank" rel="nofollow noopener noreferrer">click here.</a>https://www.docwirenews.com/docwire-pick/cardiology-picks/ace-inhibitors-and-arbs-in-hypertensive-covid-19-patients-lavie-interview/<h2><a href="https://www.docwirenews.com/cardiology/covid-19-fatal-outcomes-cardiovascular-disease-myocardial-injury/">COVID-19, CVD, and Fatal Outcomes at Ground Zero</a></h2>Researchers from a single center in Wuhan, China, the original epicenter of the COVID-19 outbreak, looked at 187 patients with laboratory-confirmed&nbsp;<a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/covid-19-coronavirus-cardiovascular-disease-caregivers-patients/">COVID-19</a> infections (144 of whom were discharged and 43 who died during the course of the study). Plasma troponin-T and NT-proBNP levels during hospitalization and impending death were increased significantly compared with admission values in patients who did not survive. There were while no significant dynamic changes of troponin-T levels, and NT-proBNP was observed in survivors. &ldquo;Myocardial injury is significantly associated with fatal outcome of COVID-19, while the prognosis of patients with underlying cardiovascular disease but without myocardial injury is relatively favorable,&rdquo; the authors wrote.https://www.docwirenews.com/cardiology/covid-19-fatal-outcomes-cardiovascular-disease-myocardial-injury/<h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/dapagliflozin-heart-failure-reduced-ejection-fraction-diabetes/">Dapagliflozin Shows Benefits for HFrEF Patients Regardless of Diabetes</a></h2>Patients who had <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/sacubitril-valsartan-heart-failure-paragon/">heart failure</a> with reduced ejection fraction (HFrEF) in this <a href="https://jamanetwork.com/journals/jama/fullarticle/2763950">JAMA </a>study (n=4,744) were given a once-daily dose of 10 mg dapagliflozin (or placebo) added to regular therapy. The primary study outcome was composite worsening heart failure or cardiovascular death, and outcomes were analyzed by diabetes status. &ldquo;In this exploratory analysis of a randomized trial of patients with&nbsp;<a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/beta-blockers-renal-impairment-heart-failure/">HFrEF</a>, dapagliflozin compared with placebo, when added to recommended therapy, significantly reduced the risk of worsening heart failure or cardiovascular death independently of diabetes status,&rdquo; the researcher wrote of the results.https://www.docwirenews.com/docwire-pick/cardiology-picks/dapagliflozin-heart-failure-reduced-ejection-fraction-diabetes/&nbsp;&nbsp;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Cardio Round-up: COVID-19 Updates, Interview, and More

Cardiology

There is more COVID news in this week's Round-up, including an interview with Dr. Carl J. "Chip" Lavie about some commonly used drugs for treating hypertension and their use ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe